We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

188 hedge funds and large institutions have $1.31B invested in Coherus Oncology in 2019 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 18

87% more call options, than puts

Call options by funds: $8.76M | Put options by funds: $4.67M

41% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 49

13% more funds holding

Funds holding: 167 → 188 (+21)

4.25% more ownership

Funds ownership: 99.43% → 103.68% (+4.3%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

7% less capital invested

Capital invested by funds: $1.41B → $1.31B (-$96.2M)

Holders
188
Holders Change
+21
Holders Change %
+12.57%
% of All Funds
3.7%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
46
Increased
69
Reduced
49
Closed
18
Calls
$8.76M
Puts
$4.67M
Net Calls
+$4.09M
Net Calls Change
-$6.73M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$29.9M
2
Ameriprise
Ameriprise
Minnesota
+$16.1M
3
Temasek Holdings
Temasek Holdings
Singapore
+$15.2M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$13.4M
5
State Street
State Street
Massachusetts
+$13M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$79.1M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$42.8M
3
DM
Deerfield Management
New York
-$31.2M
4
Invesco
Invesco
Georgia
-$7.8M
5
Citadel Advisors
Citadel Advisors
Florida
-$7.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
Adage Capital Partners
51
Adage Capital Partners
Massachusetts
$4.05M -$5.07M -275,000 -55%
APM
52
Avidity Partners Management
Texas
$3.86M +$3.96M +214,500 New
California Public Employees Retirement System
53
California Public Employees Retirement System
California
$3.71M +$1.68M +91,258 +80%
ACM
54
Atika Capital Management
New York
$3.51M +$175K +9,500 +5%
Mirae Asset Global Investments
55
Mirae Asset Global Investments
South Korea
$3.04M -$1.02M -55,461 -25%
PIM
56
Platinum Investment Management
Australia
$2.89M -$147K -7,974 -5%
Arrowstreet Capital
57
Arrowstreet Capital
Massachusetts
$2.85M +$2.92M +158,510 New
DIA
58
Dana Investment Advisors
Wisconsin
$2.85M +$270K +14,618 +10%
EAM
59
Erste Asset Management
Austria
$2.77M – – –
BG
60
Bellevue Group
Switzerland
$2.67M -$976K -52,935 -26%
TRSOTSOK
61
Teachers Retirement System of the State of Kentucky
Kentucky
$2.58M -$284K -15,394 -10%
AA
62
ALPS Advisors
Colorado
$2.54M +$2.61M +141,365 New
Rafferty Asset Management
63
Rafferty Asset Management
New York
$2.46M -$342K -18,555 -12%
JGC
64
J. Goldman & Co
New York
$2.45M +$2.51M +136,049 New
Bank of Montreal
65
Bank of Montreal
Ontario, Canada
$2.44M +$2.39M +129,810 +2,390%
Renaissance Technologies
66
Renaissance Technologies
New York
$2.31M +$2.36M +128,000 New
TCM
67
Tekla Capital Management
Massachusetts
$2.25M -$1.29M -70,000 -36%
NAM
68
Nexpoint Asset Management
Texas
$2.25M – – –
GAM
69
Gotham Asset Management
New York
$2.21M +$1.94M +104,968 +599%
CCM
70
Cadence Capital Management
Massachusetts
$2.09M -$254K -13,780 -11%
PFC
71
Phocas Financial Corp
California
$2.04M +$2.09M +113,548 New
PAMU
72
Pictet Asset Management (UK)
United Kingdom
$2.02M +$2.07M +112,298 New
Massachusetts Financial Services
73
Massachusetts Financial Services
Massachusetts
$2.02M +$1.75M +94,733 +550%
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
$1.91M +$69.2K +3,753 +4%
Los Angeles Capital Management
75
Los Angeles Capital Management
California
$1.82M +$1.38M +74,987 +284%
1 2
3
4 5

CHRS Hedge Fund Activity: Q4 2019 in Review

188 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q4 2019, worth a combined $1.31B — down 6.8% from $1.41B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new CHRS positions and 18 closed out — a net gain of 28 holders — while 69 added to existing stakes and 49 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $29.9M. The largest seller was Wellington Management Group, cutting an estimated $79.1M.

  • 188 institutional investors held Coherus Oncology (CHRS) as of Q4 2019, up from 167 in Q3 2019.
  • Funds reported $1.31B of Coherus Oncology stock for Q4 2019, down 6.8% quarter-over-quarter.
  • 46 funds opened new Coherus Oncology positions in Q4 2019 and 18 closed out, a net change of +28 holders.
  • The largest Coherus Oncology buyer in Q4 2019 was AllianceBernstein, an estimated $29.9M added.
  • The largest Coherus Oncology seller in Q4 2019 was Wellington Management Group, an estimated $79.1M sold.

Based on aggregated 13F filings for Q4 2019.